Timely and rational handling of side effects of drugs is one of the key factors for the success of antiretroviral therapy for HIV+ patients.
Timely and rational handling of side effects of drugs is one of the key factors for the success of antiretroviral therapy for HIV+ patients.
Timely and rational handling of side effects of drugs is one of the key factors for the success of antiretroviral therapy for HIV+ patients. A: 正确 B: 错误
Timely and rational handling of side effects of drugs is one of the key factors for the success of antiretroviral therapy for HIV+ patients. A: 正确 B: 错误
Q4 – Which proposal is true? A: 1- Annual risk of progression from latent TB infection (LTBI) to TB disease in HIV negative subjects is 5%-10% B: 2- Antiretroviral therapy (ARV) decreases the risk of active TB in HIV positive patients C: 3- Antiretroviral therapy (ARV) must be initiated early (2 weeks) after active TB treatment in all forms of tuberculosis, including those with central nervous system (CNS) involvement
Q4 – Which proposal is true? A: 1- Annual risk of progression from latent TB infection (LTBI) to TB disease in HIV negative subjects is 5%-10% B: 2- Antiretroviral therapy (ARV) decreases the risk of active TB in HIV positive patients C: 3- Antiretroviral therapy (ARV) must be initiated early (2 weeks) after active TB treatment in all forms of tuberculosis, including those with central nervous system (CNS) involvement
And you could expect quite a lot to come from this. There are quite a number of success stories one can point to about how this has led to major (6) ______. The first drug for HIV/AIDS was not developed for HIV/AIDS. It was developed for cancer. It was AZT. It didnt work very well for cancer, but became the first successful antiretroviral, and you can see from the table there are others as well.
And you could expect quite a lot to come from this. There are quite a number of success stories one can point to about how this has led to major (6) ______. The first drug for HIV/AIDS was not developed for HIV/AIDS. It was developed for cancer. It was AZT. It didnt work very well for cancer, but became the first successful antiretroviral, and you can see from the table there are others as well.